MKC 231

Known as: MKC-231 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2007
0119942007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
MKC-231, a putative cholinergic activity, is reported to improve learning and memory impaired in AF64A-treated animals. MKC-231… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2008
2008
The effect of MKC-231 on acetylcholine (ACh) synthesis and release was studied in the hippocampus of normal and AF64A-treated… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
MKC-231 is reported to increase high-affinity choline uptake (HACU) in vitro and improve learning impairment on a single oral… (More)
  • figure 1
  • table 1
  • figure 5
  • table 2
  • figure 4
Is this relevant?
2007
2007
This study examined the effects of subsequent, subchronic, treatment with choline uptake enhancer MKC-231 on the behavioral and… (More)
Is this relevant?
1999
1999
We investigated the effects of intracerebroventricular administration of NIK-247 (9-amino-2,3,5,6,7,8-hexahydro-1H-cyclo-penta(b… (More)
Is this relevant?
1998
1998
This study was performed to examine the neuroprotective action of 2-(2-oxopyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro… (More)
Is this relevant?
1996
1996
The pharmacological properties of MKC-231 (2-(2-oxopyrrolidin-1-yl)-N- (2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl… (More)
Is this relevant?
1994
1994
The effects of acute and chronic administration of MKC-231, a new choline uptake enhancer, and two other nootropic agents… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?